Zimmer Biomet Holdings, Inc.

Equities

ZBH

US98956P1021

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX Other stock markets 18:10:44 16/07/2024 BST			5-day change	1st Jan Change
107 ^USD	+0.45%		+1.23%	-12.03%

02:29pm	Truist Lowers Price Target on Zimmer Biomet Holdings to $117 From $130, Keeps Hold Rating	MT
03:54am	Osteopore Taps Zimmer Biomet as Exclusive Distributor in EMEA, APAC; Shares Jump 30%	MT

Tranche Update on Zimmer Biomet Holdings, Inc.'s Equity Buyback Plan announced on December 16, 2013.

January 28, 2016 at 05:39 pm

From October 1, 2015 to December 31, 2015, the company has repurchased 1,414,960 shares, representing 0.69% for $150 million. With this, the company has completed the repurchase of 5,649,480 shares, representing 3.19% for $550.47 million under the buyback announced on December 16, 2013.

Latest news about Zimmer Biomet Holdings, Inc.

Truist Lowers Price Target on Zimmer Biomet Holdings to $117 From $130, Keeps Hold Rating	01:29pm	MT
Osteopore Taps Zimmer Biomet as Exclusive Distributor in EMEA, APAC; Shares Jump 30%	02:54am	MT
Morgan Stanley Cuts Price Target on Zimmer Biomet Holdings to $120 From $130, Maintains Equalweight Rating	07-15	MT
Morgan Stanley Cuts Price Target on Zimmer Biomet Holdings to $120 From $130, Keeps Equalweight Rating	07-15	MT
Citigroup Adjusts Price Target on Zimmer Biomet to $120 From $134	07-11	MT
Citigroup Adjusts Price Target on Zimmer Biomet to $134 From $120	07-11	MT
Citigroup Adjusts Price Target on Zimmer Biomet to $120 From $134	07-10	MT
Goldman Sachs Adjusts Price Target on Zimmer Biomet Holdings to $118 From $129	07-10	MT
Stryker Corporation : Major Player in Medical Devices	07-05
Evercore ISI Adjusts Price Target on Zimmer Biomet Holdings to $115 From $130, Maintains In-Line Rating	07-02	MT
Zimmer Biomet Shares Fall Following Piper Sandler Downgrade	07-01	MT
Piper Sandler Downgrades Zimmer Biomet to Neutral From Overweight, Adjusts Price Target to $115 From $140	07-01	MT
Zimmer Biomet Holdings, Inc. Appoints Devdatt Kurdikar to its Board of Directors	06-20	CI
Zimmer Biomet Enters Co-Marketing Deal With RevelAi Health	06-12	MT
RevelAi Health and Zimmer Biomet Holdings, Inc. Announce Exclusive Multi-Year Co-Marketing Agreement to Advance Value-Based Care and Health Equity Through AI-Powered Technology	06-12	CI
Transcript : Zimmer Biomet Holdings, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 08:40 AM	06-11
Zimmer Biomet Enters Distribution Agreement with THINK Surgical to Offer TMINI Miniature Handheld Robotic System for Total Knee Arthroplasty	06-11	CI
Osteal Therapeutics, Inc. announced that it has received $50 million in funding from Zimmer Biomet Holdings, Inc., Johnson & Johnson Innovation - JJDC, Inc., HM Capital Management, LLC, GIDEON STRATEGIC PARTNERS LLC and other investors	06-04	CI
Zimmer Biomet Holdings Insider Sold Shares Worth $1,474,582, According to a Recent SEC Filing	06-04	MT
Zimmer Biomet's Limited Exposure to High-Growth Markets Spurs Revenue Concerns, UBS Says	05-31	MT
Barclays Adjusts Price Target on Zimmer Biomet to $125 From $130	05-31	MT
Barclays Adjusts Price Target on Zimmer Biomet Holdings to $125 From $130	05-31	MT
Zimmer Biomet Outlines Growth Strategy Through 2027; Board Approves $2 Billion Stock Buyback	05-29	MT
Zimmer Biomet Holdings, Inc. announces an Equity Buyback for $2,000 million worth of its shares.	05-29	CI
Transcript : Zimmer Biomet Holdings, Inc. - Analyst/Investor Day	05-29

Chart Zimmer Biomet Holdings, Inc.

Duration

Period

More charts

Company Profile

Zimmer Biomet Holdings, Inc. specializes in designing, manufacturing, and selling orthopedic and dental reconstruction implants, spinal implants, and traumatology products. Net sales break down by family of products as follows: - reconstruction implants (57.5%): knees replacement (58.8% of net sales), hips replacement (41.2%); - surgical products and traumatology equipment (22.1%); - dental, spinal and craniomaxillofacial implants (12.8%); - other (7.6%): primarily orthopedic surgery materials and instruments used during post-operative rehabilitation. At the end of 2021, the group had approximately 30 production sites worldwide. Net sales are distributed geographically as follows: Americas (61.3%), Europe/Middle East/Africa (21.3%) and Asia/Pacific (17.4%).

Sector

Medical Equipment, Supplies & Distribution

Calendar

07/08/2024 - Q2 2024 Earnings Release

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Zimmer Biomet Holdings, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

106.5 USD

Average target price

133.5 USD

Spread / Average Target

+25.31%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ZIMMER BIOMET HOLDINGS, INC.	-12.03%	21.92B
ABBOTT LABORATORIES	-6.50%	179B
MEDTRONIC PLC	-5.99%	98.84B
BECTON, DICKINSON AND COMPANY	-5.95%	65.34B
HOYA CORPORATION	+15.46%	45.41B
DEXCOM, INC.	-7.35%	44.94B
CENCORA, INC.	+9.72%	43.76B
METTLER-TOLEDO INTERNATIONAL, INC.	+13.20%	29.01B
TERUMO CORPORATION	+19.39%	25.65B
WEST PHARMACEUTICAL SERVICES, INC.	-6.52%	23.32B

Other Medical Equipment, Supplies & Distribution